Microbiome Modulation with <i>Lactobacillus rhamnosus</i> GG Potentiates Curcumin's Efficacy in Reversing Gemcitabine Resistance of Gallbladder Cancer through Gut Microbiota-PI3K/AKT Axis.

J Microbiol Biotechnol · 2026 · PMC13102627 · PMID 42014368

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Compared with the Control group, CUR+LGG alone showed a trend toward prolonged survival without statistical significance.

also in 53,322 other papers

an increasing trendno p-value reported

Introduction Gallbladder cancer (GBC) is a highly aggressive malignancy of the digestive system, and its incidence has shown an increasing trend worldwide [ 1 , 2 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Microbiome Modulation with &lt;i&gt;Lactobacillus rhamnosus&lt;/i&gt; GG Potentiates Curcumin's Efficacy in Reversing Gemcitabine Resistance of Gallbladder Cancer through Gut Microbiota-PI3K/AKT Axis.

The sentences

Microbiome Modulation with <i>Lactobacillus rhamnosus</i> GG Potentiates Curcumin's Efficacy in Reversing Gemcitabine Resistance of Gallbladder Cancer through Gut Microbiota-PI3K/AKT Axis.